BioNTech SE (BNTX)
102.90
-0.91
(-0.88%)
USD |
NASDAQ |
Sep 03, 16:00
103.85
+0.95
(+0.92%)
After-Hours: 20:00
BioNTech Cash from Investing (Quarterly) : -118.82M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -118.82M |
| March 31, 2026 | 3.101B |
| December 31, 2025 | -3.086B |
| September 30, 2025 | -994.84M |
| June 30, 2025 | -27.66M |
| March 31, 2025 | 1.312B |
| December 31, 2024 | 649.24M |
| September 30, 2024 | -162.62M |
| June 30, 2024 | -248.84M |
| March 31, 2024 | -2.501B |
| December 31, 2023 | -2.835B |
| September 30, 2023 | -1.353B |
| June 30, 2023 | -2.491B |
| Date | Value |
|---|---|
| March 31, 2023 | -789.04M |
| December 31, 2022 | -170.64M |
| September 30, 2022 | -95.10M |
| June 30, 2022 | -93.49M |
| March 31, 2022 | 322.41M |
| December 31, 2021 | -551.06M |
| September 30, 2021 | -48.80M |
| June 30, 2021 | -35.88M |
| March 31, 2021 | -34.09M |
| December 31, 2020 | -115.54M |
| September 30, 2020 | -23.24M |
| June 30, 2020 | -10.61M |
| March 31, 2020 | -16.45M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Moderna, Inc. | 329.00M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0453M |
| Mereo BioPharma Group Plc | -0.0004M |
| MediGene AG | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 12.56M |
| Cash from Financing (Quarterly) | -126.88M |
| Free Cash Flow | 424.34M |
| Free Cash Flow Per Share (Quarterly) | -0.2077 |
| Free Cash Flow to Equity (Quarterly) | -64.68M |
| Free Cash Flow to Firm (Quarterly) | -48.28M |
| Free Cash Flow Yield | 1.67% |